Uniting the Best Minds in Medicine to
Drive Life Science Innovation
Uniting the Best Minds in Medicine to
Drive Life Science Innovation
For over 75 years, TMC has been home to the brightest minds in medicine and life science. Our tradition of excellence continues today with leading academic institutions, top hospitals, visionary start-ups, and industry partners collaborating within our ecosystem to advance health, education, and research. From discovery and development to manufacturing and commercialization, TMC is helping position Houston at the forefront of life science innovation.
$ 850 M
NIH Funding in (2020)
2000 +
clinical trials annually
225 +
active start-up life science companies
21
Core CPRIT Facilities
Bringing Life-Saving Advancements to Life
Every day, the world-renowned individuals and institutions of TMC and Houston are making strides in the advancement of innovative new therapies. Each inventive discovery represents a critical step toward making patients’ lives not only better, but also longer.
- MD Anderson ushers in new era of immunotherapy
- Transforming neighborhood health by taking health care back to its roots
- Innovative gene expression studies guide congenital heart disease therapy development
- COVID-19’s long-term effect on the lungs, heart, and brain
- Drug factory implants eradiate ovarian, colorectal cancer
- Houston Methodist establishes Johnson Center for Cellular Therapies
- Polaris Program human space flight research
An Infrastructure Built for Collaborative Breakthroughs
The unique infrastructure of TMC provides an environment where collaboration is widespread and welcome. Whether enabling the united efforts of academic leaders and world-class hospitals or the shared vision of emerging start-ups and industry partners, TMC continually fosters collaborative discovery to speed the development of new solutions.
- University of Houston, UT Health, and TIRR Memorial Hermann lead Brain-Controlled Exoskeleton Trials
- Texas Children’s and Baylor College of Medicine bring new hope to women with AUFI
- MD Anderson, THI, and 7 Hills improve effectiveness of immune checkpoint blockage
- Rice Business and MD Anderson launch health care leadership program
- Baylor surgeons and Rice researchers create technology to heal heart attack injuries
- Houston Methodist and Rice launch Neuroprosthetics Collaboration
Industry Partnerships that Turn Visions into Realities
Throughout its history, TMC has leveraged industry partnerships to help ensure the highest quality patient care. Our partnerships extend even further today, with collaborative initiatives that include TMC Helix Park, TMC Innovation Factory, and TMC BioPort. From idea to implementation, we are propelling the commercialization of medical advancements by promoting never-before synergies.
- Resilience and MD Anderson launch joint venture for innovative cell therapies
- BIVACOR, Inc. and THI: One beat closer to Total Artificial Heart use in humans
- Deerfield Management and Baylor collaboratively drive drug discovery
- Ford Motor Company and Rice unite to turn car plastic into graphene
- Volumetric – 3D systems
- Prana Thoracic
- Coya Therapeutics and Houston Methodist partner to slow ALS with Treg Therapy
- ABB, CDI@TMC, JLABS@TMC
A Research Ecosystem Where Sharing Speeds Discovery
Research is at the core of all we do. In addition to the proprietary explorations of TMC Medical Campus institutions, TMC Helix Park enables collaborative translational research and TMC Innovation Factory drives visionary solutions. We also partner with the $6 billion Cancer Prevention and Research Institute of Texas (CPRIT) and other critical initiatives. What’s more, the TMC Medical Campus network of our 10 million annual patients are unrivaled in diversity in terms of both socioeconomics and medical challenges. As a result, we are a leader in NIH funding and host more clinical trials than any other US site.
- TMC ACT
- Neoadjuvant Immunotherapy at MD Anderson improves outlook in High-Risk Melanoma
- NCI awards $10.3 million+ for translational lymphoma research at Baylor, Houston Methodist, and Texas Children’s
- THI treats inflamed hearts with cell therapy to reduce risk of heart attack and stroke
- Rice and MD Anderson deliver one-two punch to leukemia with new drugs
- Novel drug combo from Houston Methodist targets triple-negative breast cancer
- Deep Brain Stimulation effective for treatment-resistant OCD at Baylor.